drugset / Trial / NCT02251184
Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH
RandomizedCrossoverOpen-labelTreatment
Summary
Comparison of pharmacokinetics of dipyridamole administered as Aggrenox versus dipyridamole administered as the immediate release formulation plus aspirin, under conditions of reduced stomach acidity.
Timeline
- Start
- 2000-10
- Primary completion
- 2000-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aggrenox | Unknown | — | — |
| Comparator | Dipyridamole | Other / unclassified | — | — |
| Comparator | Aspirin | Small molecule | — | — |
| Background | Lansoprazole | Other / unclassified | — | — |
Indications
No indication recorded.